Cyclin K Antikörper (AA 1-354)
Kurzübersicht für Cyclin K Antikörper (AA 1-354) (ABIN563802)
Target
Alle Cyclin K (CCNK) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-354
-
Verwendungszweck
- Mouse monoclonal antibody raised against a full length recombinant CCNK.
-
Sequenz
- MKENKENSSP SVTSANLDHT KPCWYWDKKD LAHTPSQLEG LDPATEARYR REGARFIFDV GTRLGLHYDT LATGIIYFHR FYMFHSFKQF PRYVTGACCL FLAGKVEETP KKCKDIIKTA RSLLNDVQFG QFGDDPKEEV MVLERILLQT IKFDLQVEHP YQFLLKYAKQ LKGDKNKIQK LVQMAWTFVN DSLCTTLSLQ WEPEIIAVAV MYLAGRLCKF EIQEWTSKPM YRRWWEQFVQ DVPVDVLEDI CHQILDLYSQ GKQQMPHHTP HQLQQPPSLQ PTPQVPQVQQ SQPSQSSEPS QPQQKDPLIL LQGWACRQPA THLLPSPLED SLLCPRPFPH PACLQLGGWG GQPG
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- CCNK (AAH15935, 1 a.a. ~ 354 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
The human HECA interacts with cyclins and CDKs to antagonize Wnt-mediated proliferation and chemoresistance of head and neck cancer cells." in: Experimental cell research, Vol. 318, Issue 5, pp. 489-99, (2012) (PubMed).
: "
-
The human HECA interacts with cyclins and CDKs to antagonize Wnt-mediated proliferation and chemoresistance of head and neck cancer cells." in: Experimental cell research, Vol. 318, Issue 5, pp. 489-99, (2012) (PubMed).
-
- Cyclin K (CCNK)
-
Andere Bezeichnung
- CCNK
-
Hintergrund
-
Full Gene Name: cyclin K
Synonyms: CPR4,MGC9113 -
Gen-ID
- 8812
Target
-